EPRX Stock

Following results that have sent the stock northward, Research Capital analyst Andre Uddin remains b... Read More

Following the announcement of a new financing, Raymond James analyst Rahul Sarugaser has lowered his... Read More

Following the release of new data, Raymond James analyst Rahul Sarugaser remains bullish about Eupra... Read More

Following new data from the company, Raymond James analyst Rahul Sarugaser has raised his price targ... Read More

More good news from Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Charts, News, An... Read More

The first half of 2023 has definitely been kinder to tech stocks, and investors have likely recouped... Read More

Raymond James analyst Rahul Sarugaser has been singing the praises of biotech company Eupraxia Pharm... Read More

Raymond James analyst Rahul Sarugaser updated clients on Thursday on biotech company Eupraxia Pharma... Read More

Shares of Eupraxia (Eupraxia Stock Quote, Charts, News, Analysts, Financials TSX:EPRX) have rallied ... Read More

After meeting with a key opinion leader in the rheumatology field, Raymond James analyst Rahul Sarug... Read More

After meeting with a key opinion leader in the gastroenterology field, Raymond James analyst Rahul S... Read More

Canadian biotech name Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Charts, News, ... Read More

Raymond James analyst Rahul Sarugaser is holding steady on biotech company Eupraxia Pharmaceuticals ... Read More

The potential is huge for Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Charts, Ne... Read More